699 related articles for article (PubMed ID: 25726090)
1. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review.
Fliefel R; Tröltzsch M; Kühnisch J; Ehrenfeld M; Otto S
Int J Oral Maxillofac Surg; 2015 May; 44(5):568-85. PubMed ID: 25726090
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate-related osteonecrosis of the jaws--a review.
Kühl S; Walter C; Acham S; Pfeffer R; Lambrecht JT
Oral Oncol; 2012 Oct; 48(10):938-947. PubMed ID: 22525606
[TBL] [Abstract][Full Text] [Related]
3. Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review.
Silva LF; Curra C; Munerato MS; Deantoni CC; Matsumoto MA; Cardoso CL; Curi MM
Oral Maxillofac Surg; 2016 Mar; 20(1):9-17. PubMed ID: 26659615
[TBL] [Abstract][Full Text] [Related]
4. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature.
Del Fabbro M; Gallesio G; Mozzati M
Eur J Cancer; 2015 Jan; 51(1):62-74. PubMed ID: 25466505
[TBL] [Abstract][Full Text] [Related]
5. [Bisphosphonate-related osteonecrosis of the jaw-after a decade has passed].
Yoneda T
Clin Calcium; 2014 Mar; 24(3):407-15. PubMed ID: 24576938
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): a systematic review.
Weber JB; Camilotti RS; Ponte ME
Lasers Med Sci; 2016 Aug; 31(6):1261-72. PubMed ID: 27025860
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates.
Shintani T; Hayashido Y; Mukasa H; Akagi E; Hoshino M; Ishida Y; Hamana T; Okamoto K; Kanda T; Koizumi K; Yoshioka Y; Tani R; Toratani S; Okamoto T
Int J Oral Maxillofac Surg; 2015 Jul; 44(7):840-4. PubMed ID: 25861974
[TBL] [Abstract][Full Text] [Related]
8. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
Assael LA
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
[TBL] [Abstract][Full Text] [Related]
9. Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC).
Thomas C; Spanidis M; Engel C; Roos FC; Frees S; Neisius A; Hampel C; Rubenwolf P; Thüroff JW; Walter C; Miederer M
Clin Oral Investig; 2016 May; 20(4):753-8. PubMed ID: 26307268
[TBL] [Abstract][Full Text] [Related]
10. Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study.
Martins MA; Martins MD; Lascala CA; Curi MM; Migliorati CA; Tenis CA; Marques MM
Oral Oncol; 2012 Jan; 48(1):79-84. PubMed ID: 21940198
[TBL] [Abstract][Full Text] [Related]
11. Dental implications of bisphophonate-related osteonecrosis.
Saldanha S; Shenoy VK; Eachampati P; Uppal N
Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
[TBL] [Abstract][Full Text] [Related]
12. Database analysis of the risk factors of bisphosphonate-related osteonecrosis of the jaw in Hungarian patients.
Veszelyné Kotán E; Bartha-Lieb T; Parisek Z; Meskó A; Vaszilkó M; Hankó B
BMJ Open; 2019 May; 9(5):e025600. PubMed ID: 31122970
[TBL] [Abstract][Full Text] [Related]
13. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
14. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
15. [Bisphosphonate-related osteonecrosis of the jaw].
Atanes-Bonome P; Atanes-Bonome A; Ríos-Lage P; Atanes-Sandoval AD
Semergen; 2014 Apr; 40(3):143-8. PubMed ID: 24001573
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
Vescovi P; Nammour S
Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
[TBL] [Abstract][Full Text] [Related]
17. A role for C-terminal cross-linking telopeptide (CTX) level to predict the development of bisphosphonate-related osteonecrosis of the jaws (BRONJ) following oral surgery?
O'Connell JE; Ikeagwani O; Kearns GJ
Ir J Med Sci; 2012 Jun; 181(2):237-42. PubMed ID: 22223192
[TBL] [Abstract][Full Text] [Related]
18. Do measurements of inflammatory mediators in blood predict recurrence in patients with bisphosphonate-related osteonecrosis of the jaws?
Mücke T; Jung M; Mitchell DA; Wolff KD; Wagenpfeil S; Stockmann P; Kesting MR; Deppe H
Br J Oral Maxillofac Surg; 2016 Apr; 54(3):286-9. PubMed ID: 26818111
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonate-related osteonecrosis of the jaw: data from the French national pharmacovigilance database.
de Boissieu P; Gaboriau L; Morel A; Trenque T
Fundam Clin Pharmacol; 2016 Oct; 30(5):450-8. PubMed ID: 27315575
[TBL] [Abstract][Full Text] [Related]
20. Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review.
Maciel AP; Quispe RA; Martins LJO; Caldas RJ; Santos PSDS
Sao Paulo Med J; 2020; 138(4):326-335. PubMed ID: 32725058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
